1. Startseite
  2. Aktien
  3. Kanada
  4. NEO EXCHANGE - NEO-L (MARKET BY ORDER)
  5. Wellbeing Digital Sciences Inc.
  6. News
  7. Andere Sprachen
    MEDI   CA94946J1084

WELLBEING DIGITAL SCIENCES INC.

(MEDI)
Schlusskurs NEO EXCHANGE - NEO-L (MARKET BY ORDER)  -  05.08.2022
0.0350 CAD   +16.67%
21.06.Wellbeing Digital Sciences ernennt Natalie Dolphin zum VP für Marketing und Investment Relations
CI
16.06.Wellbeing-Tochter KGK Science gibt positive klinische Studienergebnisse von GJ 191 (JointAlive(R)) bekannt Nahrungsergänzung bei der Behandlung von OA
CI
15.06.Wellbeing Digital Sciences Inc. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. April 2022
CI
ÜbersichtKurseChartsNewsTermineUnternehmenFinanzen 
ÜbersichtAlle NewsAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über WELLBEING DIGITAL SCIENCES INC.
20.07.Wellbeing Subsidiary KGK Science Enters Into Research Contract With Halucenex for Phase..
21.06.Wellbeing Digital Sciences Announces the Appointment of Natalie Dolphin as VP of Market..
21.06.Wellbeing Digital Sciences Appoints Natalie Dolphin as VP of Marketing and Investment R..
17.06.Wellbeing subsidiary KGK Science Announces Positive Clinical Trial Results of GJ 191 (J..
17.06.Wellbeing Digital Sciences Announces Q3 Financial Results and Provides Corporate Update
16.06.Wellbeing Digital Sciences Announces the Appointment of Terry Zimaro as Chief Financial..
16.06.Wellbeing subsidiary KGK Science Announces Positive Clinical Trial Results of GJ 191 (J..
16.06.Wellbeing subsidiary KGK Science Announces Positive Clinical Trial Results of GJ 191 (J..
15.06.WELLBEING DIGITAL SCIENCES : Interim Financial Report
15.06.Wellbeing Digital Sciences Announces the Appointment of Terry Zimaro as Chief Financial..
15.06.Wellbeing Digital Sciences Announces the Appointment of Terry Zimaro as Chief Financial..
15.06.Wellbeing Digital Sciences Inc. Reports Earnings Results for the Third Quarter and Nine..
09.06.Wellbeing subsidiary KGK Science and the International Probiotics Association (“I..
01.06.Wellbeing Digital Sciences' Dr. Corey Hilmas Invited to Participate as a Regulatory Pan..
27.05.Wellbeing Digital Sciences Announces Resignation of Chief Financial Officer
27.05.Wellbeing Digital Sciences Inc. Announces Resignation Joseph Ramelli as Chief Financial..
10.05.Wellbeing Digital Sciences Becomes a Founding Sponsor of the Women in Psychedelics Netw..
03.05.Wellbeing Digital Sciences Inc. Appoints Michael Ho as the New Medical Director, Effect..
03.05.Wellbeing Digital Sciences Welcomes Dr. Michael Ho as New Medical Director of MindScape..
28.04.Wellbeing Digital Sciences Subsidiary IRP Health Approved as Part of Coveted Chronic Pa..
25.04.Wellbeing Digital Sciences Forms Special Committee to Explore Advances in Digital Thera..
21.04.Wellbeing Digital Sciences Signs MOU with Pathway Health Regarding the Potential Sale o..
21.04.PATHWAY HEALTH CORP. (TSXV : PHC) entered into a memorandum of understanding to acquire As..
19.04.Wellbeing Digital Sciences Provides Commercial and Corporate Updates for KGK Science
14.04.Wellbeing Digital Sciences' New CEO Unveils Evolved Competitive Strategy
04.04.Wellbeing Digital Sciences Welcomes Najla Guthrie as Chief Executive Officer
28.03.Wellbeing Digital Sciences Announces Restructuring of Security-Based Compensation
22.03.Wellbeing Digital Sciences' Subsidiary KGK Science Engaged by Lophos Pharmaceuticals fo..
22.03.Wellbeing Digital Sciences' Subsidiary KGK Science Completes Clinical Study for Shakeol..
21.03.Wellbeing Digital Sciences' Subsidiary KGK Science Engaged by Lophos Pharmaceuticals fo..
18.03.Wellbeing Digital Sciences Reports Sales Results for the Second Quarter of Fiscal 2022
18.03.Wellbeing Digital Sciences Reports Financial Results for the Second Fiscal Quarter of 2..
17.03.Wellbeing Digital Sciences Inc. Reports Earnings Results for the Second Quarter and Six..
07.03.Wellbeing Digital Sciences Appoints Najla Guthrie as Chief Executive Officer
07.03.Wellbeing Digital Sciences Announces CEO Changes, Effective March 31, 2022
03.03.Wellbeing Digital Sciences Subsidiary IRP Health Receives Approval From Veterans Affair..
15.02.Wellbeing Digital Sciences Delivers its First IV Ketamine Treatment Under the Inpatient..
15.02.Wellbeing Digital Sciences Inc Delivers its First IV Ketamine Treatment Under the Inpat..
03.02.Wellbeing Digital Sciences Reveals Recent Achievement By Its KGK Science Subsidiary
02.02.Wellbeing Digital Sciences Reveals Recent Achievements by Its KGK Science Subsidiary
27.01./R E P E A T - Nova Mentis and KGK Science Form Tactical Partnership/
27.01.Nova Mentis and KGK Science Form Tactical Partnership
27.01.Wellbeing Digital Sciences' Subsidiary KGK Science Forms Tactical Partnership with Nova..
24.01.Ketamine One Changes Name to Wellbeing Digital Sciences
24.01.KetamineOne Capital Limited has Changed its Name to Wellbeing Digital Sciences Inc
17.01.Ketamine One Becomes Exclusive Ketamine Treatment Provider to Victoria Wellness
17.01.Ketamine One Becomes Exclusive Ketamine Treatment Provider to Victoria Wellness
12.01.Ketamine One Begins Trading on the OTCQB Marketplace on January 12, 2022
10.01.Ketamine One Subsidiary KGK Science Becomes the First Founding Sponsor of the “Ps..
05.01.Ketamine One Appoints Two New Members to Its Medical Advisory Board
05.01.KetamineOne Capital Limited Announces Management Appointments
2021Ketamine One Announces 2021 AGSM Results
2021Ketamine One Announces 2021 AGSM Results
2021KetamineOne Capital Limited Announces Departure of Mark Kimmins as Chief Medical Office..
2021Ketamine One Reports Strong 1Q22 Financial Results
2021KetamineOne Capital Limited Reports Earnings Results for the First Quarter Ended Octobe..
2021Ketamine One Announces Lifting of Management Cease Trade Order
2021Ketamine One Appoints Joe Ramelli as Its New Chief Financial Officer
2021Ketamine One Appoints Joe Ramelli as Its New Chief Financial Officer
2021KetamineOne Capital Limited Appoints Joe Ramelli as Its New Chief Financial Officer
2021Ketamine One Reports Audited Financial Results for the 2021 Fiscal Year
2021KetamineOne Capital Limited Reports Earnings Results for the Full Year Ended July 31, 2..
2021Myconic Capital Corp. cancelled the acquisition of NY Ketamine Medical Practice PLLC.
2021KetamineOne Adds Seattle Location to US Clinical Network
2021Ketamineone Adds Seattle Location to Us Clinical Network
2021KetamineOne Subsidiary KGK Science Helps Client Receive New Dietary Ingredient Status f..
2021Ketamine One Partners with Cognetivity Neurosciences in Collaborative Clinical Study on..
2021Ketamine One Provides Second Update on Management Cease Trade Order
2021Ketamine One Subsidiary IRP Health Opens Two New Veteran-Focused Clinics
2021Ketamine One Provides Update on Management Cease Trade Order
2021Ketamine One Announces Intention to Submit Draft Registration Statement for Proposed U...
2021Ketamine One Announces Resignation of Loreto Grimaldi From Board of Directors
2021Ketamine One Announces Resignation of Loreto Grimaldi from Board of Directors
2021Ketamine One Announces Virtual Mental Healthcare Platform in Partnership With iHealthOX
2021Ketamine One Announces Virtual Mental Healthcare Platform in Partnership With iHealthOX
1  2Weiter
Anstehende Termine für WELLBEING DIGITAL SCIENCES INC.